This paper provides a detailed critique of Parvani's 2011 systematic review examining the effectiveness of breast self-examination and breast awareness campaigns in detecting early-stage breast cancer. The critique evaluates the research methodology, study selection criteria, presentation clarity, and overall findings. The review concludes that breast self-examination offers limited clinical benefit compared to mammography and may increase unnecessary biopsies and patient stress. The paper discusses implications for clinical practice and the gap between screening methods available in developed versus developing countries, while identifying areas where future research with better-controlled variables is needed.
Breast cancer is one of the most deadly and fastest-spreading cancers in the world today. To mitigate the tide of this epidemic should ideally include preventative measures as well as proactive treatments. The purpose of the literature review "Breast self-examination, breast awareness, and practices of systematic review" by Parvani (2011) was to assess the current research findings on the degree to which breast self-examination and more general breast self-awareness campaigns were useful in increasing the rates of early detection of breast cancer.
Studies were not screened for specific levels of research rigor. General medical databases were searched for relevant studies using Medline, CINAHL, PubMed, Science Direct, and Cochrane using words such as "breast awareness," "breast self-examination," "breast cancer screening," and "breast screening" (Parvani 2011: 336). Only articles from the past five years of the authorship of the article (2005–2010) were selected. Date of publication versus standards of rigor were the determining factors.
This approach presents a notable weakness: the review prioritized temporal recency over methodological quality. By accepting any peer-reviewed study within a five-year window without explicitly screening for research design rigor or sample size adequacy, the review risked including lower-quality evidence alongside rigorous randomized controlled trials.
One drawback of this research review is that the studies are not broken down and presented in a clear, segmented format. There is no table outlining the differences between the studies. The emphasis on study selection was clearly more upon quantity rather than individualistic research analysis. The results of the studies are presented in a more general format in terms of their results without extensive pagination being devoted to breaking down their methodology.
The upside to this, however, is that the results of all the studies are presented fairly clearly, along with their implications for practice. For readers seeking practical takeaways, the review's synthesis is accessible; for researchers evaluating evidence quality or seeking methodological details, the presentation falls short of systematic review best practices.
The overall finding of the selected studies stressed the relative inadequacy of current screening methods, including mammography and breast self-examination. Of particular interest was the overall lack of efficacy of breast cancer self-screening.
Randomized controlled trials (RCTs), considered the "gold standard" of rigor in terms of research analysis, conducted in Russia and Shanghai yielded no apparent medical benefit to breast cancer self-examination. Research indicates that breast self-examination could only detect about 60% of breast cancers detected by mammography. While self-examination can detect some breast cancers not identified by mammography, there is no clinical significance in the size of the tumor and lymph nodes between those who engage in self-examination and those who do not (Parvani 2011: 336–337).
This finding is particularly striking because it contradicts decades of public health messaging promoting self-examination as a cornerstone of early detection.
The implications for current practice are extensive. Until now, breast cancer self-screening has been touted as extremely useful as a method of cancer prevention, particularly for women who cannot get regular mammography or who are younger than the usual prescribed age for the procedure. However, the literature indicates that self-screening is not particularly useful. Moreover, there are serious concerns that self-screening can actually be actively harmful because it increases the biopsy rate for non-cancerous growths, thus raising the stress level and also the healthcare costs for the patient.
Breast self-awareness was found to have a more positive link to improved health outcomes. But self-awareness is distinct from actual self-screening. This includes being aware of one's risk level and also the appropriate screening methods prescribed for one's age group and genetic profile. "Breast cancer awareness can be defined as a woman becoming familiar with her own breasts and the way that they change throughout her life" (Parvani 2011: 337).
This distinction is critical for clinical practice. Rather than recommending routine self-examination, healthcare providers should focus on educating women about normal breast changes, risk factors, and age-appropriate screening guidelines tailored to individual circumstances.
"Global screening disparities and controlled research needs"
You’re 76% through this paper. Sign up to read the remaining 1 section.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.